GE HealthCare Technologies Inc. (NasdaqGS:GEHC) agreed to acquire Intelerad Medical Systems Incorporated from Hg Capital,TA Associates and others for $2.3 billion on November 20, 2025. A cash consideration of $2.3 billion will be paid by GE HealthCare Technologies Inc. As part of consideration, $2.3 billion is paid towards common equity of Intelerad Medical Systems Incorporated. GE HealthCare intends to fund this transaction with cash on hand and proceeds from debt financing.
The transaction is subject to customary closing conditions and regulatory approvals. The expected completion of the transaction is in the first half of 2026.
Evercore Inc. acted as financial advisor for GE HealthCare Technologies Inc. Sidley Austin LLP acted as legal advisor for GE HealthCare Technologies Inc. UBS Investment Bank acted as financial advisor for Intelerad Medical Systems Incorporated. Skadden, Arps, Slate, Meagher & Flom LLP acted as legal advisor for Intelerad Medical Systems Incorporated.
GE HealthCare Technologies Inc. is a medical technology, pharmaceutical diagnostics, and digital solutions company. The Company provides integrated solutions, services, and data analytics. Its segments include Imaging, Ultrasound, Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a comprehensive portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its Ultrasound segment includes ultrasound medical devices and solutions with a portfolio of continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. The segment also includes the clinical artificial intelligence (AI) software business. Its PCS segment portfolio consists of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment consists of two business lines: contrast media and molecular imaging.
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
